From Casetext: Smarter Legal Research

Purdue Pharmaceutical Products L.P. v. Actavis Elizabeth LLC

United States Court of Appeals for the Federal Circuit
Jan 8, 2016
627 F. App'x 931 (Fed. Cir. 2016)

Summary

concluding that a finding of indefiniteness would be premature in part due to the lack of expert testimony in the record

Summary of this case from Adapt Pharma Operations Ltd. v. Teva Pharm. U.S., Inc.

Opinion

2015-1659

01-08-2016

PURDUE PHARMACEUTICAL PRODUCTS L.P., PURDUE PHARMA L.P., TRANSCEPT PHARMACEUTICALS, INC., NKA PARATEK PHARMACEUTICALS, INC., Plaintiffs-Appellants v. ACTAVIS ELIZABETH LLC, NOVEL LABORATORIES, INC., DR. REDDY'S LABORATORIES, INC., DR. REDDY'S LABORATORIES, LTD., Defendants-Appellees PAR PHARMACEUTICAL, INC., TWI PHARMACEUTICALS, INC., Defendants

CHRISTOPHER NEIL SIPES, Covington & Burling LLP, Washington, DC, argued for plaintiffs-appellants. Also represented by ERICA NICOLE ANDERSEN, MICHAEL N. KENNEDY. JACOB M. HOLDREITH, Robins Kaplan LLP, Minneapolis, MN, argued for all defendants-appellees. Defendant-appellee Novel Laboratories, Inc. also represented by MILES FINN, JEFFREY ALAN HOVDEN, OREN D. LANGER, New York, NY. SAMUEL S. PARK, Winston & Strawn LLP, Chicago, IL, for defendant-appellee Actavis Elizabeth LLC. Also represented by DAN HOANG; CHARLES B. KLEIN, Washington, DC. JEFFREY B. ARNOLD, Cantor Colburn LLP, Atlanta, GA, for defendants-appellees Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. Also represented by STEVEN M. COYLE, NICHOLAS GEIGER, Hartford, CT.


NOTE: This disposition is nonprecedential. Appeal from the United States District Court for the District of New Jersey in Nos. 2:12-cv-05311-JLL-JAD, 2:13-cv-05003-JLL-JAD, Judge Jose L. Linares.

JUDGMENT

CHRISTOPHER NEIL SIPES, Covington & Burling LLP, Washington, DC, argued for plaintiffs-appellants. Also represented by ERICA NICOLE ANDERSEN, MICHAEL N. KENNEDY. JACOB M. HOLDREITH, Robins Kaplan LLP, Minneapolis, MN, argued for all defendants-appellees. Defendant-appellee Novel Laboratories, Inc. also represented by MILES FINN, JEFFREY ALAN HOVDEN, OREN D. LANGER, New York, NY. SAMUEL S. PARK, Winston & Strawn LLP, Chicago, IL, for defendant-appellee Actavis Elizabeth LLC. Also represented by DAN HOANG; CHARLES B. KLEIN, Washington, DC. JEFFREY B. ARNOLD, Cantor Colburn LLP, Atlanta, GA, for defendants-appellees Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. Also represented by STEVEN M. COYLE, NICHOLAS GEIGER, Hartford, CT. THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (LOURIE, DYK, and HUGHES, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT January 8, 2016

Date

/s/ Daniel E. O'Toole

Daniel E. O'Toole

Clerk of Court


Summaries of

Purdue Pharmaceutical Products L.P. v. Actavis Elizabeth LLC

United States Court of Appeals for the Federal Circuit
Jan 8, 2016
627 F. App'x 931 (Fed. Cir. 2016)

concluding that a finding of indefiniteness would be premature in part due to the lack of expert testimony in the record

Summary of this case from Adapt Pharma Operations Ltd. v. Teva Pharm. U.S., Inc.
Case details for

Purdue Pharmaceutical Products L.P. v. Actavis Elizabeth LLC

Case Details

Full title:PURDUE PHARMACEUTICAL PRODUCTS L.P., PURDUE PHARMA L.P., TRANSCEPT…

Court:United States Court of Appeals for the Federal Circuit

Date published: Jan 8, 2016

Citations

627 F. App'x 931 (Fed. Cir. 2016)

Citing Cases

Chiesi U.S. Inc. v. MSN Pharm.

Likewise, in Purdue Pharm. Prod., L.P. v. Actavis Elizabeth, LLC, the court found the preamble clause “a…

Adapt Pharma Operations Ltd. v. Teva Pharm. U.S., Inc.

Additionally, the Court has not heard expert testimony or read expert reports concerning the distribution and…